secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 75562 grounded facts newest July 21, 2026, 5:23 PM ET RSS · JSON

Showing 9201–9250 of 75562

Role change

Oleg Shchegolev

Chief Technology Officer
SEMrush Holdings, Inc.
Effective
2025-03-10
Successor
William Wagner
Filed
February 26, 2025, 6:59 PM ET
On February 22, 2025, the Board also appointed Mr. Shchegolev to the role of Chief Technology Officer (“CTO”)
Departed

Anita Pramoda

Director
HCAT · Health Catalyst, Inc.
Effective
2025-03-01
Filed
February 26, 2025, 6:59 PM ET
On February 20, 2025, Anita Pramoda informed the Board of her resignation from the Board, and on February 20, 2025, the Board accepted her resignation, including her resignation from the compensation committee and transactions committee of the Board, effective March 1, 2025.
Departed

Michael P. Scarpelli

Chief Financial Officer
SNOW · Snowflake Inc.
Filed
February 26, 2025, 6:59 PM ET
On February 25, 2025, Michael P. Scarpelli notified Snowflake Inc. (the “ Company ”) of his intention to retire as the Company’s Chief Financial Officer.
Appointed

Michael Barkin

President
YOU · Clear Secure, Inc.
Effective
2025-03-31
Filed
February 26, 2025, 6:59 PM ET
the Board approved the appointment of Michael Barkin as President of the Company, effective March 31, 2025
Departed

Kenneth Cornick

Director
YOU · Clear Secure, Inc.
Filed
February 26, 2025, 6:59 PM ET
Mr. Cornick informed the Board that he will not stand for re-election as a director when his term expires at the Company’s 2025 annual meeting of shareholders.
Departed

Kenneth Cornick

Chief Financial Officer
YOU · Clear Secure, Inc.
Effective
2025-03-31
Successor
Jennifer Hsu
Filed
February 26, 2025, 6:59 PM ET
he will continue to serve as Chief Financial Officer until the commencement of his successor’s employment
Appointed

Jennifer Hsu

Chief Financial Officer
YOU · Clear Secure, Inc.
Effective
2025-03-31
Filed
February 26, 2025, 6:59 PM ET
Jennifer Hsu as Chief Financial Officer of the Company, effective March 31, 2025
Role change

Stephanie F. Pope

Chief Operating Officer
BA · BOEING CO
Effective
2025-02-19
Filed
February 25, 2025, 6:59 PM ET
Effective February 19, 2025, Stephanie F. Pope no longer held the title of Chief Operating Officer of The Boeing Company (the “Company”).
Departed

Sabrina Soussan

Director
BA · BOEING CO
Filed
February 25, 2025, 6:59 PM ET
On February 19, 2025, Sabrina Soussan and the Board of Directors of the Company decided that Ms. Soussan would not stand for re-election at the Company’s 2025 Annual Meeting of Shareholders.
Departed

Wes Morris

Group President of Poultry
TSN · TYSON FOODS, INC.
Successor
Devin Cole
Filed
February 25, 2025, 6:59 PM ET
Mr. Morris will remain with the Company to assist in the transition and plans to retire early next year.
Appointed

Devin Cole

Group President of Poultry
TSN · TYSON FOODS, INC.
Filed
February 25, 2025, 6:59 PM ET
Devin Cole has been named Group President of Poultry
Appointed

Jack Markell

Director
GHC · Graham Holdings Co
Effective
2025-02-25
Filed
February 25, 2025, 6:59 PM ET
On February 25, 2025, Jack Markell was elected to the Board of Directors of Graham Holdings Company (the “Company”).
Departed

Marcy D. Mutch

Chief Financial Officer
FIBK · FIRST INTERSTATE BANCSYSTEM INC
Effective
2025-05-31
Successor
David P. Della Camera
Filed
February 25, 2025, 6:59 PM ET
On February 20, 2025, Marcy D. Mutch notified First Interstate BancSystem, Inc. (the “Company”) of her intention to retire as a full-time employee at the end of 2025 and to step down after a transition period as the Company’s Executive Vice President and Chief Financial Officer (“CFO”) effective May 31, 2025 (the “Retirement”).
Appointed

David P. Della Camera

Chief Financial Officer
FIBK · FIRST INTERSTATE BANCSYSTEM INC
Filed
February 25, 2025, 6:59 PM ET
her announced successor, the Company’s current Deputy Chief Financial Officer, David P. Della Camera.
Departed

Suzanne P. Nimocks

director
OVV · Ovintiv Inc.
Filed
February 25, 2025, 6:59 PM ET
On February 19, 2025, Suzanne P. Nimocks notified the Board of Directors (the “Board”) of Ovintiv Inc. (the “Corporation”) that she will not stand for re-election as a director of the Corporation at the Corporation’s 2025 Annual Meeting of Shareholders.
Appointed

Stephen P. Hearn

Executive Vice President and Chief Operating Officer
BRO · BROWN & BROWN, INC.
Effective
2025-03-03
Filed
February 25, 2025, 6:59 PM ET
Mr. Hearn will become the Company's Executive Vice President and Chief Operating Officer, effective March 3, 2025.
Role change

Jeffrey M. Farber

Principal Accounting Officer
THG · HANOVER INSURANCE GROUP, INC.
Effective
2025-02-25
Filed
February 25, 2025, 6:59 PM ET
the Board of Directors of the Registrant appointed Jeffrey M. Farber, 60, the Registrant’s Executive Vice President and Chief Financial Officer, to assume the role of PAO.
Departed

Warren E. Barnes

Senior Vice President, Corporate Controller and Principal Accounting Officer
THG · HANOVER INSURANCE GROUP, INC.
Effective
2025-02-25
Successor
Jeffrey M. Farber
Filed
February 25, 2025, 6:59 PM ET
on February 25, 2025, Mr. Barnes resigned as Senior Vice President, Corporate Controller and PAO
Appointed

Eric Zinterhofer

Class II director
EL · ESTEE LAUDER COMPANIES INC
Effective
2025-01-09
Filed
February 25, 2025, 6:59 PM ET
Eric Zinterhofer was elected by the Board of Directors (the “Board”) of The Estée Lauder Companies Inc. as a Class II director on January 9, 2025.
Departed

Hemanth Varghese

President and Chief Operating Officer
Venus Concept Inc.
Effective
2025-03-28
Filed
February 25, 2025, 6:59 PM ET
On February 21, 2025, Hemanth Varghese, the Company’s President and Chief Operating Officer, advised the Company of his intention to resign from the Company, effective as of March 28, 2025.
Departed

Daniel Burgess

Director
ABUS · Arbutus Biopharma Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
Daniel Burgess
Appointed

Lindsay Androski

Chief Executive Officer
ABUS · Arbutus Biopharma Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
Ms. Androski, as Chief Executive Officer of the Company, will not receive compensation for her service as a director.
Departed

James Meyers

Director
ABUS · Arbutus Biopharma Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
James Meyers
Departed

Richard C. Henriques

Director
ABUS · Arbutus Biopharma Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
Richard C. Henriques
Departed

Frank Torti

Director
ABUS · Arbutus Biopharma Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
Frank Torti, M.D., chairperson of the Board
Departed

Melissa V. Rewolinski

Director
ABUS · Arbutus Biopharma Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
Melissa V. Rewolinski, Ph.D.
Departed

Keith Manchester

Director
ABUS · Arbutus Biopharma Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
Keith Manchester, M.D.
Appointed

Lindsay Androski

Chairperson of the Board
ABUS · Arbutus Biopharma Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
appointed Ms. Androski as chairperson of the Board
Departed

Michael J. McElhaugh

Director
ABUS · Arbutus Biopharma Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
Michael J. McElhaugh
Appointed

Mark Kaye

Director
CNMD · CONMED Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
On February 24, 2025, the Board of Directors (the “Board”) of CONMED Corporation (the “Company”) increased the size of the Board to nine directors and appointed Mark Kaye as a director effective immediately.
Role change

Jamie Miller

Chief Financial and Operating Officer
PYPL · PayPal Holdings, Inc.
Effective
2025-02-25
Filed
February 25, 2025, 6:59 PM ET
Jamie Miller, the Company’s Executive Vice President, Chief Financial Officer, has been appointed to the expanded role of Chief Financial and Operating Officer
Appointed

Sabrina Simmons

Chief Financial Officer
WOOF · Petco Health & Wellness Company, Inc.
Effective
2025-02-17
Filed
February 25, 2025, 6:59 PM ET
Sabrina Simmons succeeded Brian LaRose as the Company’s Chief Financial Officer (the “CFO Succession”), effective as of February 17, 2025
Departed

Brian LaRose

Chief Financial Officer
WOOF · Petco Health & Wellness Company, Inc.
Effective
2025-02-17
Successor
Sabrina Simmons
Filed
February 25, 2025, 6:59 PM ET
Sabrina Simmons succeeded Brian LaRose as the Company’s Chief Financial Officer (the “CFO Succession”), effective as of February 17, 2025
Appointed

Ivan Tornos

Chairman of the Board
ZBH · ZIMMER BIOMET HOLDINGS, INC.
Effective
2025-05-29
Filed
February 25, 2025, 6:59 PM ET
has appointed Ivan Tornos, the Company’s President, Chief Executive Officer and a director, as the Chairman of the Board, effective on May 29, 2025
Departed

Christopher Begley

Chairman of the Board
ZBH · ZIMMER BIOMET HOLDINGS, INC.
Effective
2025-05-29
Successor
Ivan Tornos
Filed
February 25, 2025, 6:59 PM ET
Christopher Begley, the Company’s Chairman of the Board, is not eligible for nomination by the Board for election as a director at the 2025 Annual Meeting and will retire from the Board when his current term expires at such meeting.
Appointed

Michael Farrell

Lead Independent Director
ZBH · ZIMMER BIOMET HOLDINGS, INC.
Effective
2025-05-29
Filed
February 25, 2025, 6:59 PM ET
has appointed Michael Farrell to be the Lead Independent Director of the Board, effective upon the commencement of Mr. Tornos’ service as Chairman.
Appointed

Tien Tzuo

Class I director
AMPL · Amplitude, Inc.
Effective
2025-02-22
Filed
February 25, 2025, 6:59 PM ET
On February 22, 2025, the Board of Directors (the “Board”) of Amplitude, Inc. (the “Company”) appointed Tien Tzuo to serve as a Class I director
Role change

Charles Young

Chief Operating Officer
INVH · Invitation Homes Inc.
Effective
2025-03-02
Successor
Timothy Lobner
Filed
February 25, 2025, 6:59 PM ET
Charles Young, will continue to serve as the Company’s President, but will cease serving as Chief Operating Officer (principal operating officer) as of the Effective Date.
Role change

Timothy Lobner

Executive Vice President and Chief Operating Officer
INVH · Invitation Homes Inc.
Effective
2025-03-02
Filed
February 25, 2025, 6:59 PM ET
On February 21, 2025, the Board of Directors (the “Board”) of Invitation Homes Inc. (the “Company” or “Invitation Homes”) promoted Timothy Lobner, the Company’s current Executive Vice President and Head of Field Operations to the role of Executive Vice President and Chief Operating Officer (principal operating officer), effective as of March 2, 2025
Departed

John R. Miller III

Director
MIDD · MIDDLEBY Corp
Filed
February 25, 2025, 6:59 PM ET
John R. Miller III notified the Board of his intent to retire from the Board, effective upon the completion of the 2025 Annual Meeting.
Appointed

Ed Garden

Director
MIDD · MIDDLEBY Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
appointed Julie Bowerman and Mr. Garden as directors of the Company to fill the vacancies so created.
Appointed

Julie Bowerman

Director
MIDD · MIDDLEBY Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
appointed Julie Bowerman and Mr. Garden as directors of the Company to fill the vacancies so created.
Departed

Gerard Cunningham

Director
STEM · STEM, INC.
Effective
2025-02-28
Filed
February 25, 2025, 6:59 PM ET
On February 25, 2025, Gerard Cunningham notified the Board of Directors (the “Board”) and the Corporate Secretary of Stem, Inc. (the “Company”) of his resignation from the Board effective February 28, 2025 for personal reasons.
Appointed

Dr. Syed Mubeen Jawahar Hussaini

chief technology officer
HYSR · SUNHYDROGEN, INC.
Effective
2025-02-21
Filed
February 25, 2025, 6:59 PM ET
On February 21, 2025, Dr. Syed Mubeen Jawahar Hussaini was appointed chief technology officer of SunHydrogen, Inc.
Departed

Aaron Sullivan

Executive Vice President, Chief Financial Officer, Treasurer and Secretary
LVO · LiveOne, Inc.
Effective
2025-02-19
Successor
Ryan Carhart
Filed
February 25, 2025, 6:59 PM ET
who notified the Company on the Effective Date that he is leaving the Company to pursue another professional opportunity effective as of the Effective Date.
Role change

Ryan Carhart

Chief Financial Officer, Treasurer and Secretary
LVO · LiveOne, Inc.
Effective
2025-02-19
Filed
February 25, 2025, 6:59 PM ET
Effective as of February 19, 2025 (the “Effective Date”), LiveOne, Inc. (the “Company”) appointed Ryan Carhart, the Company’s current Vice President and Controller, as the Company’s Chief Financial Officer, Treasurer and Secretary, to succeed Aaron Sullivan
Departed

Aaron Sullivan

Executive Vice President, Chief Financial Officer, Treasurer and Secretary
PODC · PodcastOne, Inc.
Effective
2025-02-19
Successor
Ryan Carhart
Filed
February 25, 2025, 6:59 PM ET
Mr. Sullivan’s departure was not as a result of any dispute with the Company.
Appointed

Ryan Carhart

Chief Financial Officer
PODC · PodcastOne, Inc.
Effective
2025-02-19
Filed
February 25, 2025, 6:59 PM ET
Effective as of February 19, 2025 (the “Effective Date”), PodcastOne, Inc. (the “Company”) appointed Ryan Carhart, the Company’s current Vice President and Controller, as the Company’s Chief Financial Officer, Treasurer and Secretary, to succeed Aaron Sullivan
Appointed

Jerome Durso

Director
ALT · Altimmune, Inc.
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
On February 24, 2025, the Board of Directors (the “Board”) of Altimmune, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased its size from eight to ten directors and appointed Teri Lawver and Jerome Durso as directors of the Board.
Appointed

Teri Lawver

Director
ALT · Altimmune, Inc.
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
On February 24, 2025, the Board of Directors (the “Board”) of Altimmune, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased its size from eight to ten directors and appointed Teri Lawver and Jerome Durso as directors of the Board.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.